Teva enlists House M.D. actress to amp up migraine awareness

Jennifer Morrison

Teva Pharmaceutical ($TEVA) wants to get the word out about migraines, and the company has tapped House M.D. actress Jennifer Morrison to lead the charge.

Morrison, who has had migraines for three years, shares her personal experience as part of Teva’s latest online campaign, The site has educational information about migraines and also prominently features a video with Morrison.

Teva sells a migraine prevention patch, Zecuity, acquired in its $114 million buyout of NuPathe in 2014. The Isreal-based drugmaker is also working on a migraine-fighting CGRP antibody, TEV-48125. The monthly injection recently went into Phase III testing, and it's in a race with other CGRP prospects in the field, including one from Eli Lilly & Co.


The 13th Annual Digital Pharma East

Digital Pharma East returns to the Pennsylvania Convention Center September 17–20, bringing together over 1000 attendees from biotech and pharma, to better understand how to present business plans, justify budget and innovation, and de-risk proposals getting shut down — essentially, understand how they can return to the office and become champions for their internal digital needs. Join us and save 15% on standard rates when you register with Discount Code DPE19Fierce.

Heightening migraine awareness can't hurt Zecuity's prospects, and it could lay the groundwork for a marketing push if and when Teva's new med is approved. Enter Morrison, who talks about her personal experiences with the malady in a web video.

In the video, Morrison walks around her backyard and house. In one scene, she strolls around the pool with a script in her hand, and in others, she sits on a sofa discussing her battle with migraines.

“I think the hardest part about suffering from migraines is that you never know when it’s going to happen,” Morrison says in the video. “For me, obviously that’s tough working in the film industry. I can’t step away from the set. I can’t stop doing my job. I can’t call in sick; there’s no one to replace me.”

The scene then moves to Morrison sitting in a kitchen scrolling through on a tablet. “I think a lot of people out there are suffering from migraines and they don’t even know,” Morrison said. “I think More to Migraine will be a great place for them to turn to start understanding what it is that they’re dealing with and to understand the questions that they can ask their healthcare provider so they can get to the bottom of the best case scenario for them.”

The site includes different interactive boxes, including one with 5 surprising facts about migraine and another that lists 10 common migraine triggers. Other boxes list treatment options, lifestyle tips for preventing migraines and a list of four things that a patient might experience during a migraine attack.

Teva on the site also encourages people to talk to their doctor about migraine. The site has three questions that patients can ask their doctor about migraine, and a link under the questions encourages individuals to save the questions to their email inbox.

- here’s the site
- read Teva’s statement

Special Report: The top 10 pharma companies by 2014 revenue - Teva

Related Articles:
Lilly and Teva tout new migraine data amid a crowded race
NuPathe nixes Endo's buyout offer to hook up with Teva
Teva, Allergan generics deal on track to close in June: Analyst


Suggested Articles

Contradicting analysts' observations, Novartis CEO dubbed Zolgensma “one of the most successful launches from an access standpoint in rare diseases.”

Rather than routine use, Kisqali’s coverage on NHS is available only through the Cancer Drugs Fund, the same limitation Verzenio got in the field.

Publicis Health's live pitchfest, with celeb judges and an audience of pharma and ad insiders, crowned a smart device as winner.